tiprankstipranks
Trending News
More News >
Larimar Therapeutics, Inc. (LRMR)
NASDAQ:LRMR

Compare Larimar Therapeutics (LRMR) vs. Competitors

Compare
1,106 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Larimar Therapeutics
$4.49
$466.43M
78.88%
5 Buy
0 Hold
0 Sell
Strong Buy
Omeros
$11.00
$779.91M
20.88%
3 Buy
1 Hold
0 Sell
Strong Buy
Vanda
$7.12
$420.85M
-2.36
44.72%
4 Buy
1 Hold
0 Sell
Strong Buy
Foghorn Therapeutics
$5.00
$293.50M
-4.58
21.36%
7 Buy
0 Hold
0 Sell
Strong Buy
Candel Therapeutics
$4.97
$364.04M
-7.84
-39.76%
4 Buy
1 Hold
0 Sell
Strong Buy
Neumora Therapeutics, Inc.
$2.51
$419.39M
-1.30
116.38%
6 Buy
0 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
LRMR
Larimar Therapeutics
4.49
2.21
96.93%
OMER
Omeros
11.00
1.98
21.95%
VNDA
Vanda
7.12
2.30
47.72%
FHTX
Foghorn Therapeutics
5.00
0.78
18.48%
CADL
Candel Therapeutics
4.97
-3.69
-42.61%
NMRA
Neumora Therapeutics, Inc.
2.51
1.31
109.17%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts